LANXESS completes acquisition of biocides specialist INTACE

Cologne
To determine the efficacy of biocidal products, different samples are examined under the microscope.
Ulla Anne Giesen
LANXESS strengthens its biocides business with the acquisition of INTACE. The Paris-based biocide company is a manufacturer of specialty fungicides for the packaging industry.

Specialty chemicals company LANXESS completed the acquisition of the French company INTACE SAS on March 1, 2021. The Paris-based biocide company is a manufacturer of specialty fungicides for the packaging industry. The parties have agreed not to disclose the purchase price.

The biocides businesses now acquired account for annual sales in the mid single-digit million euro range. LANXESS will integrate them into the Biocides business line within its Material Protection Products business unit. The products are used in particular in paper, paperboard, soap packaging, labels and banknotes.

Information for editors:
All global LANXESS news releases and their accompanying photos can be found at http://press.lanxess.com.
Recent photos of the Board of Management and other LANXESS image material are available at http://photos.lanxess.com.

 

MORE ABOUT THIS TOPIC

PRESS RELEASE
Ion exchange resins of the Lewatit range for manufacturing of ultra pure water

LANXESS ion exchange resins applied in hydrogen production

April 15, 2024
PRESS RELEASE
LANXESS at InCosmetics 2023 in Barcelona

LANXESS presents extensive portfolio for the cosmetics industry

April 04, 2024
PRESS RELEASE
Adiprene Green

Sustainable, high performing systems and additives for the polyurethane industry

March 28, 2024
PRESS RELEASE
The new module of the LewaPlus design software from LANXESS enables the dimensioning of ion exchange systems for food applications.

LANXESS’ LewaPlus design software receives numerous new functions

March 27, 2024
PRESS RELEASE
Since August 1, 2013, specialty chemicals Group LANXESS is steering its global business from the LANXESS Tower in Cologne.

LANXESS expects earnings improvement for fiscal year 2024

March 14, 2024